A detailed history of Commerzbank Aktiengesellschaft transactions in Pfizer Inc stock. As of the latest transaction made, Commerzbank Aktiengesellschaft holds 342,361 shares of PFE stock, worth $9.91 Million. This represents 0.32% of its overall portfolio holdings.

Number of Shares
342,361
Previous 265,288 29.05%
Holding current value
$9.91 Million
Previous $7.36 Million 30.11%
% of portfolio
0.32%
Previous 0.24%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 22, 2024

BUY
$25.26 - $29.6 $1.95 Million - $2.28 Million
77,073 Added 29.05%
342,361 $9.58 Million
Q1 2024

May 10, 2024

BUY
$25.89 - $29.73 $607,275 - $697,346
23,456 Added 9.7%
265,288 $7.36 Million
Q4 2023

Sep 30, 2024

SELL
$26.13 - $33.94 $3.11 Million - $4.03 Million
-118,866 Reduced 34.72%
223,495 $6.43 Million
Q4 2023

Feb 01, 2024

BUY
$26.13 - $33.94 $300,416 - $390,208
11,497 Added 4.99%
241,832 $6.96 Million
Q3 2023

Sep 30, 2024

SELL
$32.09 - $37.51 $4.25 Million - $4.96 Million
-132,363 Reduced 38.66%
209,998 $6.97 Million
Q3 2023

Nov 09, 2023

BUY
$32.09 - $37.51 $2.67 Million - $3.13 Million
83,349 Added 56.71%
230,335 $7.64 Million
Q2 2023

Sep 30, 2024

SELL
$36.12 - $41.79 $6.16 Million - $7.13 Million
-170,525 Reduced 49.81%
171,836 $6.3 Million
Q2 2023

Aug 04, 2023

BUY
$36.12 - $41.79 $3.63 Million - $4.2 Million
100,581 Added 216.75%
146,986 $5.39 Million
Q1 2023

Sep 30, 2024

SELL
$39.39 - $51.28 $10.6 Million - $13.7 Million
-268,006 Reduced 78.28%
74,355 $3.03 Million
Q1 2023

Jun 08, 2023

BUY
$39.39 - $51.28 $1.83 Million - $2.38 Million
46,405 New
46,405 $1.89 Million
Q4 2022

Sep 30, 2024

SELL
$41.75 - $54.5 $11.4 Million - $14.9 Million
-273,106 Reduced 79.77%
69,255 $3.55 Million
Q4 2022

Jun 08, 2023

BUY
$41.75 - $54.5 $1.77 Million - $2.31 Million
42,405 New
42,405 $2.17 Million
Q3 2022

Sep 30, 2024

SELL
$43.76 - $53.42 $10.6 Million - $12.9 Million
-241,131 Reduced 70.43%
101,230 $4.43 Million
Q3 2022

Jun 08, 2023

BUY
$43.76 - $53.42 $1.86 Million - $2.27 Million
42,405 New
42,405 $1.86 Million
Q2 2022

Oct 01, 2024

SELL
$46.53 - $55.17 $13.1 Million - $15.6 Million
-282,096 Reduced 82.4%
60,265 $3.16 Million
Q1 2022

Oct 01, 2024

SELL
$45.75 - $56.69 $7.47 Million - $9.26 Million
-163,280 Reduced 47.69%
179,081 $9.27 Million
Q4 2021

Oct 01, 2024

SELL
$41.32 - $61.25 $4.44 Million - $6.58 Million
-107,433 Reduced 31.38%
234,928 $13.9 Million
Q2 2020

Jul 21, 2020

SELL
$30.12 - $36.54 $8.28 Million - $10 Million
-275,040 Closed
0 $0
Q1 2020

Apr 29, 2020

SELL
$27.03 - $38.62 $18 Million - $25.8 Million
-667,154 Reduced 70.81%
275,040 $8.98 Million
Q4 2019

Jan 17, 2020

BUY
$32.92 - $37.36 $5.51 Million - $6.25 Million
167,227 Added 21.58%
942,194 $36.9 Million
Q3 2019

Oct 17, 2019

SELL
$32.49 - $42.13 $9.13 Million - $11.8 Million
-281,161 Reduced 26.62%
774,967 $27.8 Million
Q2 2019

Jul 23, 2019

SELL
$36.98 - $41.52 $6.65 Million - $7.47 Million
-179,808 Reduced 14.55%
1,056,128 $45.8 Million
Q1 2019

May 13, 2019

SELL
$37.5 - $41.2 $5.5 Million - $6.04 Million
-146,562 Reduced 10.6%
1,235,936 $52.5 Million
Q4 2018

Feb 06, 2019

BUY
$38.47 - $43.86 $4.54 Million - $5.18 Million
118,132 Added 9.34%
1,382,498 $60.3 Million
Q3 2018

Nov 13, 2018

BUY
$34.47 - $41.81 $13.9 Million - $16.8 Million
402,526 Added 46.71%
1,264,366 $55.7 Million
Q2 2018

Aug 10, 2018

BUY
$32.98 - $35.16 $4.34 Million - $4.62 Million
131,461 Added 18.0%
861,840 $31.3 Million
Q1 2018

May 01, 2018

BUY
$31.91 - $37.02 $5.85 Million - $6.79 Million
183,426 Added 33.54%
730,379 $25.9 Million
Q4 2017

Jan 26, 2018

SELL
$33.26 - $35.29 $2.57 Million - $2.72 Million
-77,144 Reduced 12.36%
546,953 $19.8 Million
Q3 2017

Nov 13, 2017

SELL
$31.0 - $34.15 $6.54 Million - $7.2 Million
-210,850 Reduced 25.25%
624,097 $22.3 Million
Q2 2017

Aug 09, 2017

BUY
N/A
834,947
834,947 $28 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $162B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Commerzbank Aktiengesellschaft Portfolio

Follow Commerzbank Aktiengesellschaft and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Commerzbank Aktiengesellschaft , based on Form 13F filings with the SEC.

News

Stay updated on Commerzbank Aktiengesellschaft with notifications on news.